Experiment summary for ENCSR812FNU
doi:10.17989/ENCSR812FNU
Summary
- Status
- released
- Assay
- ChIP-seq (TF ChIP-seq)
- Target
- CTCF
- Biosample summary
- Homo sapiens foreskin keratinocyte male newborn (2-4 days) treated with 1.2 mM calcium for 5.5 days
- Biosample Type
- primary cell
- Replication type
- anisogenic
- Description
- CTCF ChIP-seq on primary keratinocytes in day 6 of differentiation
- Treatments
- 1.2 mM calcium (CHEBI:86158) for 5.5 days
- Nucleic acid type
- DNA
- RNA integrity number
- 8.7 [1-1]6.8 [2-1]
- Platform
- Illumina HiSeq 4000
- Controls
Attribution
Genomics of Gene Regulation Project
- Lab
- Michael Snyder, Stanford
- Award
- U01HG007919 (Michael Snyder, Stanford)
- Project
- GGR
- External resources
- Aliases
- michael-snyder:ggr-skin-chipseq-CTCF-day6
- Date submitted
- December 9, 2016
- Date released
- October 10, 2017
- Treatment Time Series
- ENCSR368WHD
- Annotation (BPNet-model)
- Tags
- Factorbook
Encyclopedia Integration
Anisogenic replicates
Anisogenic replicate | Technical replicate | Summary | Biosample | Antibody | Library |
|---|---|---|---|---|---|
| 1 | 1 | Homo sapiens male newborn (2-4 days) foreskin keratinocyte primary cell treated with 1.2 mM calcium for 5.5 days | ENCBS389AUD | ENCAB830JLB | ENCLB134JON |
| 2 | 1 | Homo sapiens male newborn (2-4 days) foreskin keratinocyte primary cell treated with 1.2 mM calcium for 5.5 days | ENCBS135YLX | ENCAB830JLB | ENCLB021PUV |